• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发于长期克罗恩病患者的淀粉样变性,该患者使用英夫利昔单抗治疗。

Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.

机构信息

Gastroenterology Department, Instituto Portugus de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.

出版信息

BioDrugs. 2010 Dec 14;24 Suppl 1:15-7. doi: 10.2165/11586250-000000000-00000.

DOI:10.2165/11586250-000000000-00000
PMID:21175229
Abstract

Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.

摘要

系统性 AA 淀粉样变性是许多慢性炎症性疾病的严重并发症。它与克罗恩病有关,这意味着炎症负担高到足以使淀粉样纤维在组织中形成沉积物。本文报告了一例在患者临床状况良好时发生这种并发症的病例,生物标志物和内镜检查显示在抗肿瘤坏死因子 α 治疗下疾病处于不活动或轻度活动状态。

相似文献

1
Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.继发于长期克罗恩病患者的淀粉样变性,该患者使用英夫利昔单抗治疗。
BioDrugs. 2010 Dec 14;24 Suppl 1:15-7. doi: 10.2165/11586250-000000000-00000.
2
Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.英夫利昔单抗诱导治疗对克罗恩病相关的继发性系统性淀粉样变性的影响:病例报告及文献复习。
J Gastrointestin Liver Dis. 2013 Sep;22(3):333-6.
3
Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.抗TNF-α治疗作为克罗恩病并发症的肾淀粉样变。
QJM. 2014 Jan;107(1):57-9. doi: 10.1093/qjmed/hct112. Epub 2013 May 16.
4
Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.强直性脊柱炎和克罗恩病的关联,经英夫利昔单抗治疗后得到成功缓解。
BioDrugs. 2010 Dec 14;24 Suppl 1:37-9. doi: 10.2165/11586220-000000000-00000.
5
Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease.英夫利昔单抗定期维持治疗对克罗恩病相关系统性淀粉样变性的疗效。
Inflamm Bowel Dis. 2011 Jul;17(7):E67-8. doi: 10.1002/ibd.21720. Epub 2011 Apr 20.
6
Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.英夫利昔单抗治疗克罗恩病相关的系统性淀粉样变性
J Crohns Colitis. 2011 Apr;5(2):171-2. doi: 10.1016/j.crohns.2011.01.005. Epub 2011 Feb 15.
7
Systemic amyloidosis with Crohn's disease treated with infliximab.用英夫利昔单抗治疗的克罗恩病伴系统性淀粉样变性
Inflamm Bowel Dis. 2008 Mar;14(3):431-2. doi: 10.1002/ibd.20289.
8
[Secondary (AA) amyloidosis in Crohn's disease].[克罗恩病中的继发性(AA型)淀粉样变性]
Acta Med Croatica. 2011;65(3):271-8.
9
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.英夫利昔单抗和其他抗肿瘤坏死因子 α 治疗药物治疗炎症性肠病。
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.
10
Infliximab in the treatment of amyloidosis secondary to Crohn's disease.英夫利昔单抗治疗克罗恩病继发淀粉样变性。
Nefrologia. 2012 May 14;32(3):385-8. doi: 10.3265/Nefrologia.pre2012.Feb.11332.

引用本文的文献

1
Idiopathic AA amyloidosis presenting with initial abdominal pain: a case report and literature review.以腹痛为首发表现的特发性AA型淀粉样变性:一例病例报告及文献复习
Front Med (Lausanne). 2025 Aug 18;12:1640436. doi: 10.3389/fmed.2025.1640436. eCollection 2025.
2
Insights into renal and urological complications of inflammatory bowel disease.炎症性肠病的肾脏和泌尿系统并发症的见解
World J Nephrol. 2024 Sep 25;13(3):96574. doi: 10.5527/wjn.v13.i3.96574.
3
Renal Amyloidosis and Crohn Disease.肾淀粉样变性与克罗恩病
Ochsner J. 2021 Fall;21(3):291-295. doi: 10.31486/toj.20.0129.